NASDAQ:AFIB Acutus Medical (AFIB) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsSEC Filings About Acutus Medical Stock (NASDAQ:AFIB) Get Acutus Medical alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume7,037 shsMarket Capitalization$3 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Acutus Medical, Inc. was a medical technology company focused on improving the diagnosis and treatment of cardiac arrhythmias, particularly atrial fibrillation. Headquartered in Carlsbad, California, the company developed technologies for cardiac electrophysiology procedures, which use catheters and imaging systems to identify and treat abnormal heart rhythms. Its principal product was the AcQMap 3D Imaging and Mapping System, designed to create detailed, real-time maps of the heart’s electrical activity and anatomy. The system was intended to help physicians locate sources of arrhythmias and guide catheter ablation procedures. Acutus also developed related electrophysiology products, including mapping catheters, access sheaths and other procedural tools. Founded in 2011, Acutus Medical served hospitals and electrophysiology specialists in the United States and select international markets. The company became publicly traded on the Nasdaq under the symbol AFIB in 2020. Its subsequent corporate operations and product ownership changed as the company pursued strategic alternatives, so historical descriptions of Acutus Medical primarily relate to its cardiac mapping and ablation technology business.AI Generated. May Contain Errors. Read More Receive AFIB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Acutus Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AFIB Stock News HeadlinesAFIB Acutus Medical, Inc. - Seeking AlphaJuly 1, 2025 | seekingalpha.comEnChannel Medical to Acquire Acutus Medical AcQMap™ Electrophysiology AssetsJuly 1, 2025 | finance.yahoo.comShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he says has never existed before. In a similar setup in the past, select investors saw $1,000 turn into over $1 million within a few years. Del Real just released a full video breakdown of what is driving this move and how to prepare. | Digest Publishing (Ad)Acutus Medical Stock Short Interest Report | OTC:AFIB | BenzingaMay 26, 2025 | benzinga.comAcutus Medical Reports Full Year 2024 Financial ResultsMarch 24, 2025 | globenewswire.comAcutus Medical Announces Operational DownsizingDecember 4, 2024 | globenewswire.comAcutus Medical Reports Q3 2024 Financial ResultsNovember 20, 2024 | markets.businessinsider.comStudy reveals COVID-19 vaccine safety in patients with atrial fibrillation/flutterNovember 14, 2024 | msn.comSee More Headlines AFIB Stock Analysis - Frequently Asked Questions How were Acutus Medical's earnings last quarter? Acutus Medical, Inc. (NASDAQ:AFIB) posted its quarterly earnings data on Thursday, November, 11th. The company reported ($0.94) earnings per share for the quarter, missing the consensus estimate of ($0.92) by $0.02. The firm had revenue of $4.60 million for the quarter, compared to analyst estimates of $6.02 million. Acutus Medical had a negative trailing twelve-month return on equity of 311.64% and a negative net margin of 272.74%. Does Acutus Medical have any subsidiaries? Acutus Medical subsidiaries include these companies: Acutus Medical N.V.. When did Acutus Medical IPO? Acutus Medical (AFIB) raised $126 million in an IPO on Thursday, August 6th 2020. The company issued 7,400,000 shares at a price of $16.00-$18.00 per share. J.P. Morgan, BofA Securities and William Blair served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers. How do I buy shares of Acutus Medical? Shares of AFIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Acutus Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Acutus Medical investors own include Enterprise Products Partners (EPD), NVIDIA (NVDA), Arista Networks (ANET), Meta Platforms (META), PayPal (PYPL) and Rio Tinto (RIO). Company Calendar Last Earnings11/11/2021Today9/25/2026Next Earnings (Estimated)11/13/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:AFIB CIK1522860 Webwww.acutusmedical.com Phone442-232-6080Fax442-232-6081Employees85Year Founded2011Profitability EPS (Trailing Twelve Months)($0.11) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$81.66 million Net Margins-272.74% Pretax Margin-30.32% Return on Equity-311.64% Return on Assets-11.57% Debt Debt-to-Equity RatioN/A Current Ratio1.85 Quick Ratio1.57 Sales & Book Value Annual Sales$7.16 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($0.03) per share Price / BookN/AMiscellaneous Outstanding Shares29,912,000Free Float28,228,000Market Cap$3 thousand OptionableNo Data Beta5.73 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:AFIB) was last updated on 9/26/2026 by MarketBeat.com Staff. From Our PartnersA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | Sponsored"How Much Can I Actually Spend Each Year With $2.5M Saved?"Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...SmartAsset | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredAnalyst nicknamed “The Prophet” issues new warning for AmericaWhitney Tilson exposed a major company on 60 Minutes in an Emmy-winning investigation - the stock lost nearly ...Stansberry Research | SponsoredThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...Chaikin Analytics | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredBuffett's Final Warning: "The Dollar Is Going to Hell"On May 3rd, 2025, Warren Buffett looked at his shareholders for the last time and said: "The dollar is going t...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acutus Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acutus Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
